Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Contract Sales Reps in Japan Likely to Increase to 6,000 in 2021: Industry Group
April 15, 2016
- Japan at a Crossroads as Investment Destination, World’s Eyes Riveted on Govt’s Signals: PhRMA Local Chief
April 13, 2016
- EFPIA Japan Chief to Call for “Real Dialogue” at Today’s Public-Private Policy Confab
April 12, 2016
- Asian Industry Groups Agree to Continue Efforts to Improve Access to Innovative Medicines in Asia
April 11, 2016
- Front-Loaded Price Cuts Necessary for Drugs Like Opdivo: JMA’s Nakagawa
April 7, 2016
- Japan Pharma Groups Step Up Lobbing Campaigns to Skirt Further Drug Cost Cuts
April 7, 2016
- Generic Use Rate at 56.1% in October-December 2015: JGA
April 1, 2016
- JPMA Issues Notification Urging Member Companies to Strengthen Internal Ad Review Systems
March 25, 2016
- FPMAJ Braced for Thorny Path Ahead Even If Sales Tax Postponed, Revenue Falls Would Weigh on Industry: Chief
March 18, 2016
- Discuss Role of Drugs in Overall Social Security System: Full Interview with FPMAJ Pricing Affairs Chief
March 18, 2016
- “Huge-Seller” Re-Pricing Eroding Predictability of Japanese System: FPMAJ’s Kamoya
March 10, 2016
- PhRMA Japan Committee Sets Out Guiding Principles for MSLs
February 26, 2016
- FY2016 Reimbursement Policy Reform “Tough” on Industry: JPMA
February 19, 2016
- Top MHLW Bureaucrat Says 80% Generic Share “Achievable”
February 16, 2016
- Former JMA Pres. Eitaka Tsuboi Dies at 86
February 15, 2016
- EFPIA Japan Lays Out Basic Principles on MSL Activities
February 4, 2016
- Japanese Pharma Market to Shrink 30% over 10 Years with Annual Revisions: New PhRMA Japan Chief
January 22, 2016
- JPMA Expels Kaketsuken over GMP Violations, Cover-Up
January 22, 2016
- PhRMA Japan Representative Ira Wolf Dies at 70
January 19, 2016
- JPMA Head Hints “Free Pricing” Could Be an Option in System Overhaul
January 18, 2016
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…